1. 1) Juneja S., Gupta K., Kaushal S., J. Pharmacol. Pharmacother., 4, 78–80 (2013). https://doi.org/10.4103/0976-500X.107698
2. 2) Bonello L., Lemesle G., Laine M., “Ticagrelor is the best antiplatelet agent for pretreatment in patients with ACS,” American College of Cardiology 2016.: ‹/06/13/10/01/ticagrelor-is-the-best-antiplatelet-agent-for-pretreatment-in-patients-with-acs›, cited 19 January, 2021.
3. 3) Bach R. G., “Cardiac Intensive Care,” ed. by Brown D. L., third ed., Elsevier, the Netherlands, 2019, pp. 117–138.
4. 4) United States Pharmacopeia, Pharmacopeial Forum, 44, 573–578 (2019).
5. 5) European Pharmacopeia, 10.4, 5573–5574